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Abstract: Previous  studies have  shown positive effects of  long‐term  resveratrol  (RSV)  supplementation  in preventing





cerebral  cortices. A  number  of  genes  and  pathways  that were  differentially modulated  in  these  dietary  interventions
indicated an exacerbation of neuroinflammation  (e.g., oxidative  stress markers, apoptosis, NF‐κB activation)  in HFS‐fed
animals  and  protection  by  RSV  treatment.  The  decreased  expression  of  mitochondrial  aldehyde  dehydrogenase  2,
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INTRODUCTION 
 
Worldwide incidence of obesity is at an all-time high, 
with more than 1.1 billion adults being classified as 
overweight or obese. The rise in obesity rates has a 
growing impact on the incidence of metabolic 
syndrome, cardiovascular disease, type-2 diabetes and 
cancer, and the cost of caring for obesity-related 
pathologies remains a huge economic burden, with 
$147-210 billion going towards the care of patients each 
year [1]. Epidemiological studies have shown a 
consistent link between increased body mass index at 
mid to late life and a stronger risk of late-onset 
dementia [2]. High-fat diet has been associated with 
central inflammation, brain insulin resistance, and 
cognitive decline leading to progressive neuro-
degeneration [3], and resveratrol (RSV; 3, 4’, 5-
trihydroxy-trans-stilbene) supplementation can 
attenuate central inflammation and improve memory 
deficits in HFD-fed mice [4].   
 
RSV is a naturally occurring polyphenol compound that 
is found in a variety of foods including, but not limited 
to, wines, grape juice, nuts, and berries.  Since 1940, 
RSV has generated considerable interest in the scientific 
community due to its ability to protect against a variety 
of diseases, including type-2 diabetes, cardiovascular 
disease, and cancers [5]. In addition, RSV has been 
recently proposed to play a critical role in the reduction 
of neuroinflammation caused by cytokines [6] and 
preservation of the cerebromicrovasculature density in 
cerebral endothelial cells [7, 8]. Obesity has been 
associated with marked increase in 4-hydroxynonenal 
(4-HNE), a membrane lipid peroxidation byproduct that 
induces mitochondrial oxidative stress leading to 
neuroinflammation and progressive neurodegeneration 
[9, 10].  RSV confers antioxidant protection by reducing 
formation of reactive oxygen species and counteracting 
the cytotoxic effects of 4-HNE in PC12 cells in vitro 
[11]. Additionally, RSV improves endothelial function 
and cerebral vascular density [12, 13] by increasing 
levels of vascular endothelial growth factor (VEGF) 
[14], which enhances angiogenesis [15] and attenuates 
ischemic brain damage [16].   
  
Some clinical trials have been conducted to date to 
assess the role of RSV supplementation in brain 
function and/or neuroinflammation [17-20]. RSV 
dietary supplementation lowers infection-related 
neuroinflammation and impairment in working memory 
in mice [21] while it significantly increases cerebral 
blood flow and improves memory function in patients 
with an off-balance metabolism (reviewed in ref. [5]). 
More recently, it has been suggested that polyphenols 
are important to consume in old age as they may offer 
protection against neuroinflammation and help protect 
against cognitive decline [22].  The prefrontal cortex is 
the critical brain site for decision-making and other 
essential components of executive function [23] and 
middle-aged individuals with childhood-onset type 1 
diabetes display poorer cognitive function [24]. 
Moreover, peripheral glucose dysregulation that 
commonly occurs with obesity is also associated with 
high rates of cognitive impairment [25-29]. Because of 
the inherent limitation of performing biochemical and 
histochemical analyses on post-mortem brain tissue 
from patients, the objective of this study was to set out a 
research protocol to compare various parameters of 
cerebral neuroinflammation in middle-aged male rhesus 
monkeys fed a high-fat, high-sucrose (HFS) diet 
without and with RSV supplementation for 2 years. 
Using this experimental model, we recently reported 
that RSV prevents pancreatic β-cells dedifferentiation 
[30], promotes metabolic and inflammatory adaptations 
in visceral white adipose tissue [31], and reduces the 
HFS-induced inflammation and stiffening of the central 
arterial wall [32]. In the present study, the prefrontal 
cortices on the same cohort of treated animals were 
used to test the hypothesis that RSV supplementation 
may prevent impairment in cerebral vasculature and 
confer neuroprotection through inhibition of oxidative 




Assessment of resveratrol accumulation in monkey 
cerebrospinal fluid  
 
Adult male rhesus monkeys (average age at baseline 
10.5 ± 0.4 years) were fed a SD, HFS or HFS 
supplemented with RSV (HFS+R) diet for 24 months. 
Following euthanasia, RSV was detected in CSF of 
rhesus monkey on HFS+R diet, but not in SD- or HFS-
fed animals (Fig. 1). No attempts were made to identify 
metabolites of RSV; however, we previously reported 
the detection of RSV and resveratrol-3-O-sulfate in the 
serum of HFS+R-fed animals, but not of resveratrol-4’-
O-glucuronide nor 3-O-glucuronide, which were below 
the minimum quantitation limits [30]. There are no data 
available about concentrations of RSV in CSF in year 1. 
 
Resveratrol supplementation alters gene expression 
profiles in cerebral cortex of HFS-fed monkeys 
 
Whole genome microarray analysis was performed on 
cerebral cortex tissues of middle-aged male rhesus 
monkeys fed for two years either with SD, HFS or 
HFS+R diet. Principal component analysis (PCA) 
demonstrated a clear separation of the three 
experimental groups (Fig. 2A). The  dissimilarity  in  the  
  

















































pattern of gene expression between the HFS_SD and 
HFS+R_HFS pairwise comparisons is graphically 
represented as heat maps (Fig. 2B), and indicates that 
RSV supplementation provides a transcriptional profile 
distinct from that elicited by HFS diet alone. Gene 
ontology analyses of biological processes highlighted 
56 out of a total of 143 GO terms that were shared 
between HFS_SD and HFS+R_HFS pairwise 
comparisons (Fig. 2C). Of these, there were 55 GO 
terms (55/56) enriched by genes that were differentially 
expressed between HFS and HFS+R diets, with 
“Regulation of transcription DNA dependent”, “Zinc 
ion binding” and “Ubiquitin cycle” among the top 
expressed GO terms (Fig. 2D). Significantly regulated 
genes were then organized into functional pathways 
using parametric analysis of gene-set enrichment 
(PAGE) analysis. Of the 84 genesets modified between 
the two pairwise comparisons, 18 were shared and 
populated by genes that were differentially expressed by 
HFS and HFS+R (Fig. 2E). “Alzheimers_Disease_ 
Down”, “Diab_Neph_Down” and “Ageing_Brain_Up” 
were among the pathways that were significantly 
downregulated by HFS and markedly reversed with 
RSV supplementation (Fig. 2F). Among the 3461 genes 
whose expression was significantly modified under 
these experimental conditions, 14.1% of the transcripts 
(488/3461) were shared in response to HFS and 
HFS+R, of which 218 genes (corresponding to 44.7% of 
the shared transcripts) moved in the same direction by 
both interventions (39 and 179 genes up- and down-
regulated, respectively), while 270 genes (55.3% of the 
shared transcripts) were reciprocally altered by HFS and 
HFS+R (Fig. 2G). Fig. 2H depicts graphically the 
enrichment of these reciprocally regulated genes 
associated with the HFS_SD and HFS+R_HFS pairwise 
comparisons. The gene encoding the metallothionein 
MT1H transcript, which is inducible by ROS-mediated 
generation of lipid peroxides [33], was the most 
upregulated in response to HFS compared to SD, with a 
Z-ratio of +10.53 (Fig. 2H). Other genes upregulated by 
HFS included KCNS1 and KCNK12, two voltage-gated 
potassium channel modulatory subunits present in the 
brain [34, 35]. This finding is consistent with recent 
evidence showing that inflammation can alter 
expression of neuronal potassium channel subunit 
mRNAs [36]. BBOX1 was the most downregulated 









Figure 1.  Accumulation of RSV  in monkey CSF. At  the 
time  of  sacrifice,  CSF  from  SD,  HFS  and  HFS+R  animals was 
collected and  the amount of unconjugated RSV measured by 
MS/MS analysis. Upper panel, a CSF  sample  from  SD  control 
was  spiked  with  2.5  ng/ml  RSV.  The  detection  of  RSV  is 
indicated by *.   
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and represented one of many genes that exhibited a 
reciprocal pattern of expression with RSV treatment (Fig. 
2H). The BBOX1 gene encodes gamma butyrobetaine 
hydroxylase, an enzyme implicated in the L-carnitine 


















































maturation of BBOX1 mRNA is nutritionally regulated to 
adjust L-carnitine biosynthesis to the energy supply [38]. 
The raw data file and the filtered, normalized results are 
available online in the Gene Expression Omnibus, 




















































Figure  2. Resveratrol  supplementation  elicits differential  gene  expression profiles  in  the  frontal  cerebral  cortex of HFS‐fed  rhesus
monkeys. (A) Visualization of the principal component analysis (PCA) performed on gene expression data sets from the brain of rhesus 
  






















Semantic indexing heatmap analysis [39, 40] of the 
monkey cortical brain microarray dataset identified 
enriched GO terms that were implicitly involved in 
inter-related functional networks associated with 
synaptic transmission, axon injury and oxidation-
reduction processes, when comparing HFS to HFS+R 
cohorts (Fig. 2I). Several genes whose transcripts have 
been associated with cortical development and neuronal 
transmission were impacted by RSV supplementation in 
HFS-fed monkeys, and included CHRNA5, GRIN2B and 
KCNB1 [41-43]. Expression of a vital component in 
actin-cytoskeleton organization in axon, SPTBN1 [44], 
was also affected in the HFS+R cohort. Of significance, 
HFS diet caused an increase in the expression of CST3, 
a transcript that correlates positively with cognitive 
impairment in the elderly [45], which did not occur with 
RSV supplementation. The expression of GRIN2B, 
SPTBN1 and KCNB1 transcripts relevant to CNS was 
verified by quantitative RT-PCR analysis (Fig. 2J). The 
validated genes belong to the following two GO classes: 
“Synapse part (GO:0044456)” – GRIN2B (glutamate 
receptor, ionotropic, n-methyl d-aspartate 2b) and 
KCNB1 (potassium voltage-gated channel, shab-related 
subfamily, member 1), and “Axon part (GO:0033267)” 
– SPTBN1 (spectrin, beta, non-erythrocytic 1).  
 
Expression of GRIN2B and SPTBN1 mRNA levels was 
significantly lower in HFS+R vs. SD and HFS groups, 
while the reduction in KCNB1 mRNA did not quite 
reach conventional levels of statistical significance (p= 
0.053). Nevertheless, the changes in the mRNA 
transcript levels between the microarray and 
quantitative RT-PCR data were identical in terms of 






















Resveratrol supplementation improves regional 
brain capillary density in cerebral cortex of HFS-fed 
monkeys 
 
Microscopic visualization was performed to determine 
the effect of diets on cerebral vasculature in rhesus 
monkeys. A consistent pattern of distribution was 
observed in the vascularization of the neocortex of SD-
fed animals and, by comparison, was substantially less 
in HFS brain (Fig. 3A). RSV supplementation offered 
significant protection against the HFS-mediated loss in 
capillary density in the neocortex. We then investigated 
the expression of a series of proteins implicated in 
angiogenesis, including von Hippel-Lindau protein 
(pVHL), VEGF and endothelial nitric oxide synthase 
(eNOS) using Western blot analysis. VHL encodes the 
ubiquitin ligase pVHL, and HFS diet caused a 
significant increase in pVHL levels with concomitant 
reduction in the amount of VEGF protein (Fig. 3, B and 
C), which could explain the lower vascularization in the 
neocortex of HFS-fed rhesus monkeys (Fig. 3A). A 
trend toward reduced accumulation of pVHL without 
upregulation of VEGF was observed in HFS+R 
compared to HFS cerebral cortex extracts (Fig. 3, B and 
C).  
 
Cerebral blood flow requires the generation of nitric 
oxide and eNOS-derived nitric oxide appears to exhibit 
neuroprotection under physiological conditions (review, 
see Ref. [46]). Some stimuli trigger the production of 
superoxide instead of nitric oxide through increased 
monomerization of eNOS and alteration in its 
enzymatic function. This phenomenon, termed eNOS 
uncoupling, exacerbates oxidative stress  and  the deple- 
monkeys maintained on standard diet (SD), high‐fat, high‐sugar diet (HFS) and HFS supplemented with resveratrol for 2 years (HFS+R). (B)
Heat maps  representing  gene  expression  profile  comparing  genes  significantly  up  (red)  and  downregulated  (blue)  in HFS  vs.  SD‐fed
controls  and HFS+R  vs. HFS.  (C) Venn diagram  illustrating  the number of  significantly up  and down  regulated GO  terms observed  in
neocortex  from HFS vs. SD  (blue  symbols) and HFS+R vs. HFS‐fed monkeys  (red  symbols).  (D) Enrichment of  the 56  shared GO  terms
visualized using a two‐dimensional graphical representation of HFS vs. SD (blue bars) and HFS+R vs. HFS (red bars). A list of three shared
GOTerms  differentially  expressed  between  the  two  pairwise  comparisons  is  provided.  (E)  Venn  diagram  illustrating  the  number  of
significantly  up  and  down  regulated  pathways  between  the  two  pairwise  comparisons.  (F)  Enrichment  of  the  18  shared  pathways
visualized using a two‐dimensional graphical representation of HFS vs. SD (blue bars) and HFS+R vs. HFS (red bars).  A list of three shared
pathways  differentially  expressed  between  the  two  pairwise  comparisons  is  provided.  (G)  Venn  diagram  illustrating  the  number  of
significantly up and down regulated genes between  the  two pairwise comparisons.  (H) Enrichment of  the 270 shared genes visualized
using  a  two‐dimensional  graphical  representation  of HFS  vs.  SD  (blue  bars)  and HFS+R  vs. HFS  (red  bars). A  list  of  six  shared  genes






Although  the  fold  changes  in  GRIN2B,  SPTBN1  and  KCNB1  expression were  small  [less  than  a  2‐fold  change],  these were  in  good
agreement with the quantitative RT‐PCR data. SD (n=4); HFS (n=10); HFS+R (n=10).  *, **, p <0.05 and 0.01, respectively.  
  















































































































Figure  3.  Resveratrol  treatment  improves  capillary  density  in  the  cerebral  cortex  of  HFS‐fed  rhesus  monkeys.  (A)
Representative  images of cerebral cortical brain capillary staining, and  their  respective quantification.  (B) Solubilized cerebral cortex
extracts  from  SD‐,  HFS‐  and  HFS+R‐fed  animals  were  resolved  by  SDS‐PAGE  under  reducing  conditions,  electrotransferred  onto
nitrocellulose membranes and subjected to immunoblotting using the indicated primary antibodies. Representative signals associated
with bands of interest are shown, including that of b‐actin, which was used as loading control. All 24 brain samples were ran on a single
gel  (Fig. S1). Nitrocellulose membrane staining was also carried out with Ponceau S dye  for protein detection.  (C) Signals associated
with VEGF and VHL proteins were normalized and represented as box plots. (D) Signals associated with eNOS and FOXO3 proteins were
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tion of nitric oxide, together with neuronal apoptosis 
and ROS release after brain injury [47]. We therefore 
examined whether the abundance and/or monomer-
dimer equilibrium of eNOS would be impacted by 
dietary stress. There was a significant increase in the 
amount of eNOS protein with a trend toward higher 
expression of its transcriptional activator FOXO3 in 
response to HFS as compared to SD-fed controls (Fig. 
3, B and D). A positive linear relationship between 
eNOS levels and FOXO3 expression was established in 
the HFS cohort (p < 0004; Fig. 3E), and this correlated 
well with a deficit in brain capillary density. Diet 
supplementation with RSV significantly reversed the 
HFS-mediated increase in the steady-state levels of 
FOXO3 and eNOS proteins (Fig. 3, B and D). Despite 
the fact that eNOS expression was actually increased by 
HFS, the eNOS dimer/monomer ratio was comparable 
to that of SD-fed controls while RSV treatment caused a 
significant elevation in the ratio (p<0.001, Fig. 3, F and 
G). Because the dimeric eNOS is the only form of the 
enzyme that produces nitric oxide [48], these results are 
consistent with improved cerebral blood flow in the 
presence of increased capillary density due to RSV 
supplementation.  
 
The endogenous level of hydrogen sulfide (H2S) dilates 
cerebral vessels by activating smooth muscle cell plasma 
membrane ATP-sensitive K+ channels. It also increases 
eNOS activity by promoting the formation of eNOS 
dimers [49]. Here, large intra-individual variations in 
H2S levels in SD, HFS and HFS+R groups were 
observed (Fig. 3H), making it impossible to determine 
whether the RSV-mediated protection in cerebral 
vasculature of HFS-fed rhesus monkeys stemmed from 
increases in H2S tissue concentration in the brain.  
 
Resveratrol supplementation and inflammatory state 
in the cerebral cortex of HFS-fed monkeys 
 
There was no significant difference in the number of 
cells positive for the microglial marker Iba1+ among the 
groups (Fig. 4A). Despite the low sample size in the SD 
group, evidence was provided for higher levels of IL-6 
in CSF after HFS feeding (p = 0.0424, Fig. 4B) and for 
the lack of difference between the HFS and HFS+R 
groups. Additionally, the increased ratio of phospho-
active to total form of NF-κB p65Rel in response to 
HFS vs. SD was not conclusive (Fig. 4, C and D), and 
neither was the difference in the activation state of 
p65Rel between the HFS+R group and HFS (p = 0.057, 
Fig. 4, A and D).  
 
A critical mechanism of transcriptional suppression of 
NF-κB involves the copper metabolism MURR1 
domain containing (COMMD) proteins through 
promotion of the ubiquitination and degradation of NF-
κB subunits [50]. Further analysis of the microarray 
dataset revealed a significant increase in COMMD10 
and COMMD3 transcripts with a concomitant reduction 
of transcripts corresponding to known NF-κB targets, 
such as NFKBIA, TNFRSF25 and IL18, in the cerebral 
cortex of HFS+R versus HFS-fed animals (Fig. 4E). 
The BCL2 family of genes is transcriptionally regulated 
by NF−κB in the brain [51], and we demonstrated here 
that diet supplementation with RSV significantly 
increased the expression of the antiapoptotic protein 
BCL2 with marked reduction in the active (cleaved) 
form of caspase 3 as compared to HFS (Fig. 4, F and 
G). Low caspase 3 cleavage was also observed in the 
HFS group as compared to SD. 
 
Various members of the sirtuin class of NAD(+)-
dependent, protein deacetylase family have been found to 
be involved in processes related to the regulation of 
inflammation and neurobiology. Whilst SIRT1 has been 
by far the most extensively studied sirtuin, there has been 
recent interest in cytoplasmic SIRT2, particularly due to 
its abundance in the CNS and its expression increasing 
with age [52]. SIRT2 plays an important role for 
neurocognitive ability in adult, middle-aged mice and 
few studies have demonstrated that inhibition of SIRT2 
reduces the aggregation of α-synuclein via modulation of 
tubulin activity to mitigate Parkinson’s toxicity [53, 54]. 
Because high-fat diet is a known inducer of NF-κB-
mediated neuroinflammation in cerebral cortex [55], we 
examined whether RSV contributes to the regulation of 
cerebral expression of SIRT2 and its activity as a bona 
fide α-tubulin deacetylase [56] in response to HFS. 
Immunoblotting revealed significant reduction in SIRT2 
protein levels caused by RSV supplementation (Fig. 4H 
and I upper panel, Supplemental Fig. 1). The decrease in 
SIRT2 levels was accompanied by higher expression of 
α-tubulin, which, in turn, led to a significant reduction in 
the acetylated/total tubulin ratio in the HFS+R cohort 
compared to the HFS group (Fig. 4H and I lower panel, 
Supplemental Fig. 1). 
  
Mitochondrial aldehyde dehydrogenase (ALDH2) is 
implicated in the metabolism and inactivation of 
reactive aldehydes, which represent major end products 
of lipid peroxidation and contributing factors in diet-
induced neuronal oxidative stress. An association has 
been reported between brain ALDH2 levels and 
protection against ischemic stroke [57]. Moreover, mice 
lacking ALDH2 exhibit endothelial dysfunction, age-
related cognitive impairment and Alzheimer’s disease 
[58]. We therefore measured the abundance of ALDH2 
protein in the cerebral cortex of HFS-fed rhesus 
monkeys and found a significant reduction in its 
expression level (Fig. 4J and K, Supplemental Fig. 1). 
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RSV supplementation helped preserve the amount of 
ALDH2 despite HFS-mediated oxidative stress, which 
may indicate substantial protection against neocortex 
damage. Consistent with this, a positive linear 



















































the anti-apoptotic BCL2 protein was established in the 
HFS+R cohort (Fig. 4L). Taken together, the results 
indicate that RSV supplementation may overcome HFS-
induced cerebrovascular dysfunction and neuroinflam-

































































The ability of RSV supplementation to promote a shift 
away from diet-induced brain inflammation towards 
increase in neuronal health in a nonhuman primate 
model of obesity highlights important implications for 
future translational studies aimed at the prevention of 
neuronal damage and brain dysfunction. The fact that 
RSV can exert neuroprotective effect in various animal 
models under high-caloric conditions is already 
established; however, our observations in Rhesus 
monkeys represent an unique opportunity to validate 
these emerging concepts and for a period far longer than 
any clinical trials to date.  
 
Our study on the long-term effect of RSV 
supplementation in metabolically impaired monkeys 
was initiated several years ago and has led to a number 
of significant observations including the decline in 
arterial wall stiffening and inflammation [32], lower 
pancreatic islet β-cell dedifferentiation [30] and 
improved insulin signaling in adipose tissue [31]. Here, 
we show that the CSF levels of IL-6 were significantly 
higher in HFS monkeys than in the SD group together 
with reduction in brain capillary density and amount of 
ALDH2 in the cerebral cortex. The gene profiling in the 
cerebral cortex of the HFS group resembled that 
previously described for physical trauma brain injury 
(TBI) in mice [59], with the most striking changes 
involving the regulation of functional pathways, notably 
“StemCell Embryonic Up”, “StemCell Neural Up”, 
“Alzheimer’s Disease Up” and “Alzheimer’s Disease 
Dn”. RSV was readily detected in CSF samples from 
the HFS+R group, along with the recovery of brain 
capillary density and protection against HFS-induced 
alteration in NF-κB transcriptional activity.  
 
HFS is associated with alterations in cerebral 
vasculature, and consumption of RSV ameliorates 
endothelial hyperpermeability in HFS-fed rats partly via 















of eNOS through homodimeric uncoupling provided a 
mechanism for diet-induced brain insult. Importantly, 
eNOS dimer stabilization was observed in the cerebral 
cortex of the HFS+R group vs HFS, and RSV 
supplementation was found to attenuate HFS-mediated 
induction of eNOS protein and its transcriptional 
activator FOXO3. The higher levels of eNOS in the 
HFS group may be an attempt in trying to improve 
blood flow in the presence of low capillary density due 
to HFS. Notable are the studies in which H2S was 
reported to affect eNOS function while playing a 
cardinal role in the protection of neurons from 
secondary injury by functioning as an anti-oxidant and 
anti-inflammatory mediator (reviewed in Ref. [61]). We 
could not demonstrate the contribution of H2S in 
modulating eNOS dimer/monomer ratio and/or activity 
due to large intra-individual variations among the 
groups. Similar to the protective effects of RSV in the 
monkey central arterial wall [32], RSV may potentially 
reduce the HFS-induced cerebrovascular inflammation 
by limiting transport of circulating cytokines across the 
blood-brain barrier, lending credence to the report of 
Chang et al. [62], who showed that high-fat diet 
supplementation with RSV for 8 weeks significantly 
reduced the disruption of the blood-brain barrier while 
protecting brain neurons in the mice from apoptotic 
insults. Based upon these results, it would have been 
interesting to perform a long-term dietary stress first 
and then initiate RSV supplementation in order to 
restore the cortical brain capillary density and protect 
against neuronal brain insults. 
  
Administration of RSV has been found to greatly 
attenuate global cerebral ischemia by reducing levels of 
pro-inflammatory cytokines and promoting a reduction 
in associated plaque formation in the rat brain [63]. In 
addition, the ability of RSV to acutely inhibit microglial 
activation is consistent with its anti-inflammatory 
activity against various neurological disorders in 
experimental mouse models [64] and in a mouse model 








acetylated  tubulin,  and  total  tubulin  levels.  (I)  Signals  associated with  bands  of  interest were  normalized  to  Ponceau  S  staining  and
represented  as  box  plots.  (J)  Representative  signals  associated  with  ALDH2  and  GAPDH,  the  latter  being  used  as  loading  control.
Membrane staining was also carried out with Ponceau S dye for protein detection. The migration of molecular‐mass markers (values in
kilodaltons) is shown on the left of the stained membrane. (K) Signal associated with ALDH2 was normalized to GAPDH and represented
as box plots.  (L) Scatterplot exploring  the significant association between ALDH2 and BCL2 protein expression with HFS+R  feeding. SD
(n=4); HFS (n=10); HFS+R (n=10). *, p < 0.05.    
  
www.impactaging.com                   907                                           AGING, May 2016, Vol. 8 No.5
minimal impact on both the activation of 
macrophage/microglial cell population and the steady 
state levels of active NF-κB p65 subunit when 
compared to the HFS group. In contrast, there was 
significant difference in the expression of genes 
involved in the inflammatory process between the HFS 
and HFS+R groups, with the RSV-treated group 
exhibiting anti-inflammatory protection. The 
deacetylase SIRT1 is a putative target of RSV action, 
and significant increase in Commd expression has been 
reported in the muscle of mice treated with the small 
SIRT1 activator, SRT2104, which was accompanied by 
SIRT1-mediated inhibition in NF-κB transcriptional 
activity [66]. Our results indicated that the SIRT1 
content in the monkey cerebral cortex was comparable 
among the three experimental groups (data not shown), 
although acetylation levels of protein targets of SIRT1 
may have been impacted. Nevertheless, we focused our 
attention toward SIRT2. SIRT2 functions as the 
predominant microtubule deacetylase in mature mouse 
cortical neurons, and impairment in tubulin 
acetylation/deacetylation activity has been associated 
with neuropathological features [67, 68]. The 
localization of SIRT2 along the microtubule network 
and the previous observation that regulation of neuronal 
morphology depends on the ability of microtubules to 
mediate intracellular transport and control local 
signaling events led us to the discovery of a significant 
reduction in SIRT2 protein expression in response to 
RSV supplementation. Unexpectedly, a decrease in the 
acetylated/total α-tubulin ratio through induction in α-
tubulin levels was observed, which suggested to us that 
other tubulin deacetylases such as HDAC6 [69] were 
refractory to RSV treatment. SIRT1 protein contains no 
significant tubulin deacetylase activity (see Fig. 3C in 
[56]). Limited studies in mice using genetic and 
pharmacological approaches to disrupt SIRT2 
expression and/or activity have generated divergent 
outcome [70, 71]. Genetic knockout of SIRT2 in a 
Huntington’s disease mouse model showed no 
improvement in tubulin acetylation and the progression 
of neurological pathologies [70], whereas treatment 
with a SIRT2 inhibitor for up to 14 weeks confers 
neuroprotection against Huntington’s related toxicity 
[71]. In our study, the benefits of treating HFS-fed 
monkeys with RSV for 2 years have been achieved 
through partial depletion of SIRT2 protein levels and 
improved neuroinflammation even though the identity 
of the molecular targets of RSV remain unknown. 
  
The microarray experiment has identified a number of 
genes that were impacted by RSV supplementation such 
as voltage-gated potassium channel modulatory 
subunits, the glutamate receptor and axonal spectrin. 
Additionally, gene sets related to oxidative stress and 
activation of NF-κB target genes were found to be 
downregulated in the HFS+R group as compared to 
HFS. It is interesting that chronic in vivo NFAT-
dependent transcription leads to pathological formation 
of neurofibrillary tangles in a mouse model of 
Alzheimer’s disease, which can be attenuated by 
polyphenols [72]. Moreover, RSV supplementation 
prevents pathological cardiac hypertrophy by inhibiting 
the transcription factor NFAT [73]. It remains to be 
established whether NFAT activation occurs in cerebral 
cortex of HFS-fed monkeys and returns to basal steady 
state levels following diet supplementation with RSV.  
 
Protection against progressive apoptotic cell death is a 
desirable feature when considering the impact of long-
term dietary stress. The increase in inflammation and 
vascular dysfunction that results from obesity and 
metabolic disorders led us to examine the expression of 
apoptosis markers in monkey cerebral cortex. As 
expected, a clear effect on BCL2 levels and amount of 
active caspase 3 was observed in the HFS+R group as 
compared to HFS, thus providing evidence of the anti-
apoptotic role of RSV against HFS-induced apoptosis. 
Though there was less active caspase 3 in cerebral 
cortex of the HFS group as compared to SD, BCL2 was 
expressed at similar levels between the two groups, 
indicating that the 2-year regimen with HFS may not 
have been sufficient to promote overt neuro-
inflammation and apoptosis-related events. 
Alternatively, the indicated difference in active caspase 
3 levels between the SD and HFS groups may not be 
conclusive due to low SD sample size. ALDH2 
expression was significantly reduced by HFS, but 
normalized with RSV supplementation in parallel with 
the increase in BCL2 levels, and this can explain the 
compensatory changes to defend the brain against diet-
induced oxidative damage leading to neuronal 
apoptosis.  
 
When combined with the observation that a 6-month 
diet supplementation with RSV improves memory in 
overweight older individuals [20], it appears likely that 
attenuation of diet-induced neuroinflammation by brain 
resident cells, e.g., activated microglia and astrocytes, 
and perivascular macrophages may provide some of the 
cognitive benefits of RSV. A 52-week administration of 
1000 mg RSV twice daily in individuals with 
Alzheimer’s disease has been found to be well tolerated 
and resulted in changes in the trajectory of some 
biomarkers compared to placebo [74]. 
 
Altogether the present work outlines the preclinical 
efficacy of RSV supplementation in the prevention or 
delay of cerebral vascular dysfunction induced by 
dietary stress in rhesus monkeys, a highly relevant 
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model of human health and disease. These findings add 
to an expending literature investigating the benefits of 




Animals and diets. Twenty-four adult (7-13 year old) 
male rhesus monkeys (Macaca mulatta) were housed at 
the NIH Animal Center. Animals were housed 
individually in standard nonhuman primate caging, in a 
temperature-regulated room (25 ± 1°C), humidity at 60 
± 20%, on a 12h light/12h dark cycle (lights on from 
6:00 to 18:00) with ad libitum access to drinking water. 
All monkeys had extensive visual, auditory, and 
olfactory but limited tactile contact with monkeys 
housed in the same room. Monkeys were monitored 
minimally 3 times daily by trained animal-care staff. All 
procedures and animal care were conducted in 
accordance with the National Institutes of Health (NIH) 
Guide for the Care and Use of Laboratory Animals in an 
AALAC-accredited facility.  
 
During baseline assessment, all monkeys were 
maintained on standard NIH monkey chow (Purina 
Mills). After baseline assessment, monkeys were quasi-
randomized to one of three dietary regimens such that 
average age and bodyweight did not differ significantly 
between groups: control diet group fed a healthy 
standard diet (SD) with 13% kcal in fat and less than 
5% sucrose by weight, high fat and sugar diet (HFS) 
group fed with 42% kcal in fat and 27% sucrose by 
weight (Harlan, Teklad, Indianapolis, IN, USA), and 
HFS + RSV (HFS+R) group fed with the same HFS diet 
plus a flavored primate treat (BioServ, Flemington, NJ, 
USA) containing 40 mg RSV (DSM Nutritional 
Products, Parsippany, NJ, USA) twice daily for one 
year. For the second year of the study, the RSV dose 
was increased to 240 mg twice a day to raise plasma 
RSV levels at 27.7 ± 8.6 ng/ml (29). No adverse effects 
to the RSV were evident. Monkeys in non-RSV groups 
received placebo treats. The RSV dose (240 mg) was 
derived from the protective dose reported in mice (22 
mg/kg) [75] and adjusted by allometric scaling to an 
average monkey body weight of 12.1 kg.  
 
All groups received 2 meals per day in allotments that 
represent ad libitum feeding. The HFS diet was 
formulated to cause weight gain and symptoms of 
metabolic syndrome, such as increased abdominal 
circumference, higher serum insulin levels after an 
intravenous glucose challenge, higher LDL-cholesterol 
but lower HDL-cholesterol levels compared to baseline 
levels, as well as lower insulin sensitivity after 24 
months on a HFS diet [30, 31]. 
Tissue sample collection, brain sectioning and 
immunofluorescence. At the end of the two-year dietary 
treatment period, monkeys were anesthetized with 
ketamine (7-10 mg/kg, IM). Following collection of 
blood and cerebrospinal fluid (CSF), animals were 
euthanized by an overdose of pentobarbital (50 mg/kg) 
and perfused with cold lactated Ringer’s solution. Brain 
and various other organs and tissues were harvested 
immediately and either frozen at -80°C or fixed for 
further analyses. All experimental procedures were 
approved by the Animal Care and Use Committee of the 
NIA Intramural Program. The final protocol number for 
this project was #379-LEG-2010. 
 
Brains were cut into 8 x 1-cm thick coronal blocks 
using a brain matrix. Each block was then cut sagittally 
along the midline. The entire left side of the brain was 
placed in 4% paraformaldehyde. Twenty-four to forty-
eight hours after placement in paraformaldehyde, left 
hemispheres were cryoprotected in 20% sucrose 
solution for one week, then frozen in Cryo-Gel 
(Electron Microscopy Sciences, Hatfield, PA, USA) for 
sectioning. Coronal sections of 70 µm were cut through 
the cortex blocks and stored free-floating in 
cryopreservative solution (25% glycerol, 25% ethylene 
glycol, 25% 0.2 M phosphate buffer, 25% water) at 
−20°C. After washing, sections were treated with 
Proteinase K solution for antigen retrieval and were 
then treated with 1% of sodium-borohydride solution. 
Brain sections were blocked in 5% BSA/TBS 
(supplemented with 0.5% Triton X-100, 0.3 M glycine 
and 1% fish gelatin) and then immunostained with 
mouse anti-CD31 (Abcam, Cambridge, MA, USA) and 
rabbit anti-Iba1 (Wako, Richmond, VA, USA) 
antibodies at 4°C. After extensive washing, brain 
sections were labeled with donkey anti-mouse IgG, 
Alexa Fluor 488 and donkey anti-rabbit IgG, Alexa 
Fluor 568 both from Life Technologies (Grand Island, 
NY, USA), and then counterstained with 4',6-
diamidino-2-phenylindole. The mounted slides were 
imaged by both fluorescence microscopy and on a Leica 
confocal microscope using 20x and 40x objectives. 
  
Capillary density in the cortex was quantified as the 
length of blood vessels <10 μm in diameter per volume 
of tissue using ImageJ software (NIH, Bethesda, MD, 
USA). The total length of capillaries was divided by the 
cortex area to obtain capillary density (length per area 
of tissue). Immunofluorescence labeling for Iba1 was 
used to identify microglia in the brain. The relative 
number of Iba1-positive microglia per region of interest 
in the cortex was calculated. The areas were analyzed 
using the area measurement tool of the MetaMorph 
software (version 7.7.9.0). In each animal, four 
randomly selected fields from the cortex were analyzed 
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in six nonadjacent sections for both staining. The 
experimenter was blinded to the groups and animal 
treatments throughout the analysis.  
 
RNA extraction, cDNA synthesis, and quantitative 
PCR. Total RNA was extracted from frozen monkey 
temporal neocortex and purified using RNeasy Mini Kit 
(Qiagen, Valencia, CA, USA). A total of 0.5-1 μg total 
RNA was converted into first-strand cDNA using the 
High-Capacity cDNA reverse transcription kit with 
random hexamers, according to the manufacturer’s 
instructions (Applied Biosystems, Foster City, CA, 
USA). SYBR Green PCR Master Mix (Applied 
Biosystems) was used for quantitative PCR reactions, 
and samples were analyzed on the 7500 Real-Time PCR 
System (Applied Biosystems). Oligonucleotide 
sequences were as follows:  
GRIN2B (XM_001088140.2), 5’-CCCAGATCCT 
CGATTTCATT-3’ and 5’- GCCAAACTGGAAGAA 
CATGG-3’; 
SPTBN1 (NM_001266968.1), 5’- CCTCTGATCGCA 
AAGCCAAGAC-3’ and 5’- CCACTCGTGTTTCCGA 
TTGAG-3’; 
 KCNB1 (NM_001265653.1), 5’-ACCGAATCCAACA 
AGAGCGT-3’ and 5’-TGCAAGCTTAAGGAT 
GCGGA-3’;  
glyceraldehyde phosphate dehydrogenase (GAPDH, 
NM_001195426.1), 5’-TGAAGCAGGCGTCGGAGG 
G-3’ and 5’-CGAAGGTGGAAGAGTGGGTG-3’.  
Rhesus monkey PCR primer pairs were purchased from 
Integrated DNA Technologies, Inc. (Coralville, IA, 
USA). Fidelity of the PCR reactions was determined by 
melting temperature analysis. All samples were run in 
triplicate for each gene. The relative gene expression 
was calculated using the ∆∆CT method normalized to 
the housekeeping gene GAPDH, whose expression 
remained constant in all experimental conditions.   
 
cDNA microarray analysis. RNA was isolated from 
rhesus monkey temporal neocortex at 24-months of 
dietary intervention using Trizol reagent (Invitrogen, 
Carlsbad, CA, USA) and further purified using RNeasy 
mini columns (Qiagen). RNA was processed, labeled 
and hybridized to Illumina HumanHT-12 V4.0 
expression beadchip using standard Illumina protocols. 
Raw data were subjected to Z normalization; individual 
genes with Z ratio > 1.5 in both directions, P value < 
0.05, and false discovery rate > 0.3 were considered 
significantly changed. The number of samples for each 
group was: SD =4, HFS =10, and HFS+R =10. Our 
expression data was tested for gene set enrichment 
using the parametric analysis of gene set enrichment 
(PAGE) method [76]. For each Z (pathway), a P value 
was also computed in JMP 6.0 to test for the 
significance of the Z score obtained. These tools are 




Protein extraction, gel electrophoresis and Western 
blotting. Frozen brain cortical tissues were 
homogenized in ice-cold lysis buffer [31], and clarified 
lysates were processed for SDS-polyacrylamide gel 
electrophoresis under reducing conditions with proteins 
transferred to nitrocellulose membranes. The 
membranes were routinely stained with the Ponceau S 
dye (Sigma-Aldrich, St-Louis, MO, USA) for the rapid 
and reversible detection of protein bands. Protein 
expression was detected using specific primary 
antibodies. Antibodies raised against Bcl2, cleaved 
caspase 3, FOXO3a, pVHL, acetyl-α-tubulin and 
phospho-p65Rel (Ser 536) were purchased from Cell 
Signaling Technology. (Danvers, MA, USA); NF-κB 
from Epitomics (Burlingame, CA, USA); eNOS from 
BD Biosciences (Franklin Lakes, NJ, USA); VEGF, 
ALDH2, SIRT2, β-actin, GAPDH and α-tubulin from 
Abcam; and HIF-1α from Cayman Chemicals (Ann 
Arbor, MI, USA). All antibodies were detected with 
horseradish peroxidase-conjugated secondary antibodies 
(Santa Cruz Biotechnology, Dallas, TX, USA) and 
visualized by enhanced chemiluminescence (GE 
Healthcare, Piscataway, NJ, USA). Quantitation of the 
protein bands was performed by volume densitometry 
using ImageJ software. 
 
Determination of dimeric and monomeric forms of 
eNOS. eNOS dimeric and monomeric species were 
separated, using low-temperature SDS–PAGE under 
reducing conditions followed by Western blot analysis, 
as described previously [77]. In brief, brain cortical 
samples were not heated and the temperature of the gel 
was maintained at 4°C during electrophoresis, which 
enabled the detection of the dimeric and monomeric 
forms of eNOS protein by immunoblotting. 
 
Hydrogen sulfide measurement. Hydrogen sulfide 
production was determined in protein lysates from 
cerebral cortex following the method described by Hine 
et al. [78]. In brief, brain tissues were homogenized in 
passive lysis buffer (Promega, Madison, WI, USA) 
followed by several rounds of flash freezing/thawing. 
After normalization for protein content with the 
bicinchoninic acid assay (Thermo Scientific Pierce, 
Rockford, IL, USA), 125 mg of lysates was added to a 
final reaction in 96-well format containing 10 mM 
cysteine and 1 mM pyridoxal 5’-phosphate. Pieces of 
lead acetate paper (15x10 cm) were made by soaking 
VWR® grade 703 blotting paper (VWR International, 
Radnor, PA, USA) in 20 mM lead acetate (Sigma-
Aldrich) and then vacuum drying, followed by their 
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positioning over the 96-well dish and incubation for 18 
h at 37°C until lead sulfide was detected but not 
saturated. Quantification was performed by volume 
densitometry using ImageJ software.  
 
Determination of IL-6 and RSV levels in CSF. IL-6 
levels in CSF were determined using a specific monkey 
ELISA kit, according to the manufacturer’s instructions 
(Invitrogen). The extraction of RSV from monkey CSF 
and its identification by mass spectrometric methods 
was undertaken as previously described [30].  
 
Statistical analysis. With regard to data analysis for 
western blotting, the nonparametric Kruskal-Wallis test 
was used to compare the three unmatched groups with 
different sample sizes (SD =4; HFS =10; HFS+R = 10). 
Rejection of the null hypothesis (p ≤ 0.05) was followed 
by Tukey post-hoc test to identify specific sample pairs 
that showed significant difference in mean ranks. P 
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antibodies.  Probing membranes with GADPH  and  β‐actin  demonstrated  equal  loading  in  each  lane.  Bands  of
interest were quantitated by densitometry and normalized to Ponceau S staining of the membranes. 
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